Skip to main content
Top
Published in: Breast Cancer Research 1/2011

Open Access 01-12-2011 | Poster presentation

TOMMY Trial (a comparison of tomosynthesis with digital mammography in the UK NHS breast screening programme) setting up a multicentre imaging trial

Authors: FJ Gilbert, MGC Gillan, MJ Michell, KC Young, HM Dobson, J Cooke, H Purushothaman, YY Lim, SM Astley, SW Duffy

Published in: Breast Cancer Research | Special Issue 1/2011

Login to get access

Excerpt

Digital breast tomosynthesis (DBT) has the potential to improve the accuracy of standard digital mammography (DM) [1]. The TOMMY Trial is a multicentre, multireader, retrospective matched comparison of the diagnostic performance of DBT and DM. …
Literature
1.
go back to reference Dobbins JT, Godfrey DJ: Digital X-ray tomosynthesis: current state of the art and clinical potential. Phys Med Biol. 2003, 48: R65-R106. 10.1088/0031-9155/48/19/R01.CrossRefPubMed Dobbins JT, Godfrey DJ: Digital X-ray tomosynthesis: current state of the art and clinical potential. Phys Med Biol. 2003, 48: R65-R106. 10.1088/0031-9155/48/19/R01.CrossRefPubMed
Metadata
Title
TOMMY Trial (a comparison of tomosynthesis with digital mammography in the UK NHS breast screening programme) setting up a multicentre imaging trial
Authors
FJ Gilbert
MGC Gillan
MJ Michell
KC Young
HM Dobson
J Cooke
H Purushothaman
YY Lim
SM Astley
SW Duffy
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2011
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2980

Other articles of this Special Issue 1/2011

Breast Cancer Research 1/2011 Go to the issue

Poster presentation

Abstract withdrawn by author

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine